RECRUITING Not applicable ClinicalTrials.gov

A Tool for Improving the Shared Decision-making Process in Patients With Non-small Cell Lung Cancer

Sponsor: Mayo Clinic • ClinicalTrials.gov ID: NCT06122064

Registry updated: 2026-08-20

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

This clinical trial compares the use of a shared decision-making communication tool during a clinical encounter to standard care for improving the quality of the shared decision-making process among patients with non-small cell lung cancer. Lung cancer patients are faced with many decisions about their treatment options. Studies have found that patients are most satisfied if they perceive an effort by their physician to share decision making and are afforded sufficient time to make their decision. Shared decision-making tools can help physicians guide the conversation, offer tailored estimates of the potential benefits, harms, and practical inconveniences of the available options, and support deliberations that take into account patient biological and biographical circumstances, goals, and priorities. Incorporating a shared decision-making communication tool into standard clinical encounters may improve the shared-decision making process as well as patient satisfaction with their treatment choice.

Interventions

Best Practice (Other)
Receive standard of care
Communication Intervention (Other)
Use shared decision-making conversation tool
Electronic Health Record Review (Other)
Ancillary studies
Survey Administration (Other)
Ancillary studies
Video Recording (Other)
Ancillary studies
Audio Recording (Other)
Ancillary studies

Eligibility criteria

Inclusion Criteria: * CLINICIANS: * All clinicians within identified departments participating are eligible (doctor of medicine \[MD\]/doctor of osteopathy \[DO\], fellows/residents, physician assistant \[PA\]/nurse practitioner \[NP\]) * PATIENTS: * Adult patients (\>= 18 years of age) * Appointments at Mayo Clinic in Rochester * Non-small cell lung cancer (NSCLC) stage \> 1B * Eligible by their oncologist for adjuvant treatment Exclusion Criteria: * Exclude patient with major barriers to provide written informed consent or to participate in shared decision-making (i.e., dementia, severe hearing or visual impairment)

Conditions

Lung Non-Small Cell Carcinoma Stage II Lung Cancer AJCC v8 Stage III Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8

Locations

Mayo Clinic in Rochester — Rochester, Minnesota, United States

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment